6.82
price up icon2.40%   0.16
after-market After Hours: 6.80 -0.02 -0.29%
loading
Aquestive Therapeutics Inc stock is traded at $6.82, with a volume of 1.74M. It is up +2.40% in the last 24 hours and up +22.00% over the past month. Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
See More
Previous Close:
$6.66
Open:
$6.68
24h Volume:
1.74M
Relative Volume:
0.63
Market Cap:
$680.12M
Revenue:
$58.36M
Net Income/Loss:
$-25.72M
P/E Ratio:
-18.73
EPS:
-0.3641
Net Cash Flow:
$-24.91M
1W Performance:
-0.29%
1M Performance:
+22.00%
6M Performance:
+133.16%
1Y Performance:
+24.23%
1-Day Range:
Value
$6.575
$6.87
1-Week Range:
Value
$6.39
$7.0844
52-Week Range:
Value
$2.12
$7.55

Aquestive Therapeutics Inc Stock (AQST) Company Profile

Name
Name
Aquestive Therapeutics Inc
Name
Phone
908-941-1900
Name
Address
30 TECHNOLOGY DRIVE, WARREN, NJ
Name
Employee
142
Name
Twitter
Name
Next Earnings Date
2025-03-05
Name
Latest SEC Filings
Name
AQST's Discussions on Twitter

Compare AQST with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
AQST
Aquestive Therapeutics Inc
6.82 805.68M 58.36M -25.72M -24.91M -0.3641
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
144.09 63.86B 9.39B 2.62B 2.22B 5.8121
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.44 41.80B 29.96B 957.25M 4.77B 0.2956
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.27 40.88B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
20.48 22.98B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
445.43 19.53B 3.08B 1.24B 1.07B 25.61

Aquestive Therapeutics Inc Stock (AQST) Upgrades & Downgrades

Date Action Analyst Rating Change
Jun-02-25 Resumed Oppenheimer Outperform
Dec-17-24 Initiated Cantor Fitzgerald Overweight
May-10-24 Initiated Leerink Partners Outperform
Apr-11-24 Initiated Piper Sandler Overweight
Mar-28-24 Initiated Raymond James Outperform
Apr-07-21 Resumed RBC Capital Mkts Outperform
Apr-22-19 Initiated H.C. Wainwright Buy
Jan-03-19 Initiated Lake Street Buy
Aug-20-18 Initiated JMP Securities Mkt Outperform
Aug-20-18 Initiated RBC Capital Mkts Outperform
View All

Aquestive Therapeutics Inc Stock (AQST) Latest News

pulisher
07:33 AM

Can Aquestive's Oral, Non-Device Epinephrine Film Capture A Share Of The Growing U.S. Market? - RTTNews

07:33 AM
pulisher
06:51 AM

Will Aquestive Therapeutics Inc. bounce back from current supportWeekly Profit Recap & Consistent Growth Equity Picks - newser.com

06:51 AM
pulisher
06:36 AM

Detecting support and resistance levels for Aquestive Therapeutics Inc.Weekly Trade Review & Weekly Watchlist for Hot Stocks - newser.com

06:36 AM
pulisher
06:33 AM

Why Aquestive Therapeutics Inc. stock could outperform in 2025July 2025 Catalysts & Daily Risk Controlled Trade Plans - newser.com

06:33 AM
pulisher
06:15 AM

Real time alert setup for Aquestive Therapeutics Inc. performanceJuly 2025 Short Interest & AI Driven Stock Reports - newser.com

06:15 AM
pulisher
05:56 AM

Volatility clustering patterns for Aquestive Therapeutics Inc.Share Buyback & High Accuracy Trade Alerts - newser.com

05:56 AM
pulisher
05:55 AM

Will Aquestive Therapeutics Inc. stock gain from strong economyJuly 2025 Weekly Recap & Advanced Swing Trade Entry Plans - newser.com

05:55 AM
pulisher
05:41 AM

Can technical indicators confirm Aquestive Therapeutics Inc.’s reversalChart Signals & Stepwise Swing Trade Plans - newser.com

05:41 AM
pulisher
01:40 AM

Long term hold vs stop loss in Aquestive Therapeutics Inc.Quarterly Profit Review & Detailed Earnings Play Alerts - newser.com

01:40 AM
pulisher
01:09 AM

Why Aquestive Therapeutics Inc. stock is trending among retail tradersProduct Launch & Low Risk Investment Opportunities - newser.com

01:09 AM
pulisher
Oct 30, 2025

Risk vs reward if holding onto Aquestive Therapeutics Inc.2025 Volatility Report & Smart Money Movement Alerts - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Aquestive Therapeutics to Attend 2025 ACAAI Annual Meeting - The Manila Times

Oct 30, 2025
pulisher
Oct 30, 2025

Aquestive Therapeutics Inc. stock chart pattern explainedMarket Risk Report & Real-Time Market Trend Scan - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Using AI based signals to follow Aquestive Therapeutics Inc.2025 Winners & Losers & Weekly Consistent Profit Watchlists - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

What Wall Street predicts for Aquestive Therapeutics Inc. stock priceGDP Growth & Safe Entry Trade Reports - newser.com

Oct 30, 2025
pulisher
Oct 30, 2025

Top chart patterns to watch in Aquestive Therapeutics Inc.July 2025 Macro Moves & Low Risk High Win Rate Stock Picks - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

Is Aquestive Therapeutics Inc. stock attractive for retirement portfoliosWeekly Trade Summary & Accurate Entry and Exit Point Alerts - newser.com

Oct 29, 2025
pulisher
Oct 28, 2025

Will Aquestive Therapeutics Inc. stock benefit from AI adoptionCPI Data & Safe Swing Trade Setup Alerts - Fundação Cultural do Pará

Oct 28, 2025
pulisher
Oct 27, 2025

Can trapped investors hope for a rebound in Aquestive Therapeutics Inc.Dividend Hike & High Accuracy Investment Signals - newser.com

Oct 27, 2025
pulisher
Oct 27, 2025

Why Aquestive Therapeutics Inc. stock attracts high net worth investors - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ET - The Manila Times

Oct 27, 2025
pulisher
Oct 27, 2025

Aquestive Therapeutics to Report Third Quarter 2025 - GlobeNewswire

Oct 27, 2025
pulisher
Oct 27, 2025

Aquestive Therapeutics (AQST) to Release Quarterly Earnings on Monday - MarketBeat

Oct 27, 2025

Aquestive Therapeutics Inc Stock (AQST) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Aquestive Therapeutics Inc Stock (AQST) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Jung Cassie
Chief Operating Officer
Oct 15 '25
Sale
7.01
67,575
473,701
240,771
Kraus Carl N
Chief Medical Officer
Oct 15 '25
Sale
7.00
20,272
141,904
282,475
Boyd Peter E.
See Remarks
Oct 15 '25
Sale
7.00
10,000
70,000
268,323
$45.46
price up icon 3.18%
$22.15
price down icon 1.86%
drug_manufacturers_specialty_generic RDY
$13.29
price down icon 1.19%
$10.36
price up icon 0.00%
$143.21
price up icon 3.75%
$445.43
price down icon 1.79%
Cap:     |  Volume (24h):